Comparative pharmacodynamic and pharmacokinetic characteristics of subcutaneous insulin glulisine and insulin aspart prior to a standard meal in obese subjects with type 2 diabetes.
Phase of Trial: Phase I
Latest Information Update: 01 Mar 2011
At a glance
- Drugs Insulin aspart; Insulin glulisine
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 05 Nov 2010 New trial record.